Literature DB >> 19228992

Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion.

Ebru Gürel1, Kirsten M Smeele, Otto Eerbeek, Anneke Koeman, Cihan Demirci, Markus W Hollmann, Coert J Zuurbier.   

Abstract

The glycolytic enzyme hexokinase (HK) is suggested to play a role in ischemic preconditioning (IPC). In the present study we determined how ischemic preconditioning affects HK activity and HKI and HKII protein content at five different time points and three different subcellular fractions throughout cardiac ischemia-reperfusion. Isolated Langendorff-perfused rat hearts (10 groups of 7 hearts each) were subjected to 35 min ischemia and 30 min reperfusion (control groups); the IPC groups were pretreated with 3 times 5-min ischemia. IPC was without effect on microsomal HK activity, and only decreased cytosolic HK activity at 35 min ischemia, which was mimicked by decreased cytosolic HKII, but not HKI, protein content. In contrast, mitochondrial HK activity at baseline and during reperfusion was elevated by IPC, without changes during ischemia. No effect of IPC on mitochondrial HK I protein content was observed. However, mitochondrial HK II protein content during reperfusion was augmented by IPC, albeit not following the IPC stimulus. It is concluded that IPC results in decreased cytosolic HK activity during ischemia that could be explained by decreased HKII protein content. IPC increased mitochondrial HK activity before ischemia and during reperfusion that was only mimicked by increased HK II protein content during reperfusion. IPC was without effect on the phosphorylation status of HK before ischemia. We conclude that IPC is associated with 1) a biphasic response of increased mitochondrial HK activity before and after ischemia, 2) decreased cytosolic HK activity during ischemia, and 3) cellular redistribution of HKII but not HKI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228992     DOI: 10.1152/japplphysiol.90537.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  28 in total

1.  Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.

Authors:  Rongxue Wu; Kirsten M Smeele; Eugene Wyatt; Yoshihiko Ichikawa; Otto Eerbeek; Lin Sun; Kusum Chawla; Markus W Hollmann; Varun Nagpal; Sami Heikkinen; Markku Laakso; Kentaro Jujo; J Andrew Wasserstrom; Coert J Zuurbier; Hossein Ardehali
Journal:  Circ Res       Date:  2010-11-11       Impact factor: 17.367

2.  Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria.

Authors:  Meiying Yang; Yanji Xu; James S Heisner; Jie Sun; David F Stowe; Wai-Meng Kwok; Amadou K S Camara
Journal:  Mitochondrion       Date:  2018-11-01       Impact factor: 4.160

3.  Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.

Authors:  Ebru Gurel; Savas Ustunova; Aysegul Kapucu; Nadim Yilmazer; Otto Eerbeek; Rianne Nederlof; Markus W Hollmann; Cihan Demirci-Tansel; Coert J Zuurbier
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

Review 4.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 5.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

6.  Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics.

Authors:  Chad M Warren; David L Geenen; Donald L Helseth; Hua Xu; R John Solaro
Journal:  J Proteomics       Date:  2010-04-12       Impact factor: 4.044

7.  Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.

Authors:  Jennifer I Drake; Herman J Bogaard; Shiro Mizuno; Berrick Clifton; Bin Xie; Yuan Gao; Catherine I Dumur; Paul Fawcett; Norbert F Voelkel; Ramesh Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-30       Impact factor: 6.914

8.  Adaptation to chronic continuous hypoxia potentiates Akt/HK2 anti-apoptotic pathway during brief myocardial ischemia/reperfusion insult.

Authors:  David Kolar; Milada Gresikova; Petra Waskova-Arnostova; Barbara Elsnicova; Jana Kohutova; Daniela Hornikova; Pavel Vebr; Jan Neckar; Tereza Blahova; Dita Kasparova; Jiri Novotny; Frantisek Kolar; Olga Novakova; Jitka M Zurmanova
Journal:  Mol Cell Biochem       Date:  2017-03-13       Impact factor: 3.396

9.  Pathophysiological consequences of TAT-HKII peptide administration are independent of impaired vascular function and ensuing ischemia.

Authors:  Rianne Nederlof; Chaoqin Xie; Otto Eerbeek; Anneke Koeman; Dan M J Milstein; Markus W Hollmann; Egbert G Mik; Alice Warley; Richard Southworth; Fadi G Akar; Coert J Zuurbier
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

10.  Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice.

Authors:  Kirsten M Smeele; Otto Eerbeek; Anneke Koeman; Rick Bezemer; Can Ince; Sami Heikkinen; Markku Laakso; Arnold de Haan; Gert Schaart; Maarten R Drost; Markus W Hollmann; Coert J Zuurbier
Journal:  Pflugers Arch       Date:  2010-02-25       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.